News
News
ACMA Chairman, CEO, Dr. William Soliman discusses Johnson & Johnson, Purdue Pharma, and the Opioid Crisis
Dr. William Soliman discusses Johnson & Johnson, Purdue Pharma, the opioid crisis and where the pharmaceutical industry goes from here.
Accreditation Council for Medical Affairs Appoints Accera CEO, Dr. Charles Stacey to its Board of Governors
The ACMA has appointed Dr. Charles Stacey, President and CEO of Accera Pharmaceuticals to its Board of Governors. Dr. Stacey is the President and CEO
Accreditation Council Appoints Pharma Power Players, former Otsuka CEO, Bob Oliver and Astellas Executive, S. Bob Chib to its Board of Governors
The ACMA has appointed two power players to its Board of Governors Bob Oliver and S. Bob Chib. Bob Oliver, Recent CEO of V ClinBio,
Jason Aryeh, Life Sciences Investment Fund Manager and Pharmaceutical Industry Expert, Appointed to the Board of Governors of the ACMA
The ACMA announces its appointment of Jason Aryeh, Life Sciences Investment Fund Manager and pharmaceutical industry expert, to its board of governors today. Mr. Aryeh
ACMA Partners with the Council for Continuing Pharmaceutical Education of Canada
The partnership between the ACMA and Council for Continuing Pharmaceutical Education (CCPE) will enable more medical affairs and MSL professionals in Canada to become Board
Chicago Leads Battle Against Opioid Crisis
ACMA featured on page 19 as Accreditor working with drug reps and medical affairs professionals. Read Full Article: http://www.cmsdocs.org/news-publications/chicago-medicine-magazine/2018-issues/June2018Issue.pdf